Drug Profile
Birch pollen allergy immunotherapy - LETI Pharma
Alternative Names: Depigmented Glutaraldehyde Polymerized Birch Pollen Allergenic Extract; Depigoid Birch; Depigoid Birch 5000Latest Information Update: 08 Sep 2021
Price :
$50
*
At a glance
- Originator LETI Pharma GmbH
- Class Allergens; Peptide vaccines; Peptides; Skin disorder therapies; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Rhinoconjunctivitis; Seasonal allergic rhinitis
- No development reported Atopic dermatitis
Most Recent Events
- 08 Sep 2021 No development reported - Phase-III for Rhinoconjunctivitis (In adolescents, In children, In adults) in Finland (SC)
- 08 Sep 2021 No development reported - Phase-III for Rhinoconjunctivitis (In adolescents, In children, In adults) in Germany (SC)
- 08 Sep 2021 No development reported - Phase-III for Rhinoconjunctivitis (In adolescents, In children, In adults) in Latvia (SC)